Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
ADC Therapeutics
ADC Therapeutics
(ADCT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zynlonta
Loncastuximab tesirine
2021-04-23
Large b-cell lymphoma diffuse
,
B-cell lymphoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loncastuximab tesirine
leukemia
,
lymphoid leukemia
,
b-cell chronic lymphocytic leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
burkitt lymphoma
,
central nervous system neoplasms
,
follicular lymphoma
,
mantle-cell lymphoma
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
hodgkin disease
Epratuzumab
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
philadelphia chromosome
,
lymphoid leukemia
Ademetionine
neoplasms
Edrecolomab
non-hodgkin lymphoma
,
lymphoma
,
b-cell lymphoma
Calcium dobesilate
waldenstrom macroglobulinemia
Sodium lactate
large b-cell lymphoma diffuse
,
lymphoma
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
hodgkin disease
Bevifimod
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lymphoma
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
CAMIDANLUMAB
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
urinary bladder neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
lymphoma
,
hodgkin disease
,
myelodysplastic syndromes
,
neoplasms
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
preleukemia
CAMIDANLUMAB TESIRINE
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
breast neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
lymphoma
,
hodgkin disease
,
myelodysplastic syndromes
,
neoplasms
,
myeloproliferative disorders
,
myelodysplastic-myeloproliferative diseases
,
preleukemia
Loncastuximab
leukemia
,
lymphoid leukemia
,
b-cell chronic lymphocytic leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
burkitt lymphoma
,
central nervous system neoplasms
,
follicular lymphoma
,
mantle-cell lymphoma
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
hodgkin disease
Nepidermin
breast neoplasms
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
Odronextamab
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
,
b-cell lymphoma
Palifosfamide
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
,
b-cell lymphoma
Microcrystalline cellulose
large b-cell lymphoma diffuse
,
lymphoma
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
hodgkin disease
Caelyx
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use